Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Study of Anifrolumab for Patients with Cutaneous Lupus Erythematosus to Measure Changes in Skin and Blood Inflammation and Clinical Outcomes

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia France Hungary Poland Spain
  • Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

    Recruiting

    1 1
    Investigated drugs:
    Belgium Bulgaria France Germany Hungary Italy +5
  • Study on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

    Recruiting

    1 1 1
    Investigated drugs:
    Belgium Bulgaria France Germany Hungary Italy +5
  • Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Greece Poland Romania Spain
  • Study on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Greece Poland Spain
  • Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Bulgaria Denmark France Germany Greece +7
  • Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    Investigated drugs:
    Bulgaria Greece Poland Romania Spain
  • Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Czechia Germany Spain